SS Innovations International (NASDAQ:SSII – Get Free Report) and Solventum (NYSE:SOLV – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings.
Valuation and Earnings
This table compares SS Innovations International and Solventum”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SS Innovations International | $42.49 million | 13.63 | -$12.13 million | ($0.06) | -48.17 |
| Solventum | $8.31 billion | 1.83 | $1.56 billion | $8.18 | 10.92 |
Profitability
This table compares SS Innovations International and Solventum’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SS Innovations International | -23.73% | -26.77% | -15.01% |
| Solventum | 17.26% | 25.09% | 8.78% |
Analyst Recommendations
This is a summary of recent recommendations for SS Innovations International and Solventum, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SS Innovations International | 1 | 0 | 0 | 0 | 1.00 |
| Solventum | 1 | 3 | 8 | 0 | 2.58 |
SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 142.21%. Solventum has a consensus price target of $92.80, indicating a potential upside of 3.87%. Given SS Innovations International’s higher probable upside, equities research analysts plainly believe SS Innovations International is more favorable than Solventum.
Volatility and Risk
SS Innovations International has a beta of -1.94, indicating that its stock price is 294% less volatile than the S&P 500. Comparatively, Solventum has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.
Summary
Solventum beats SS Innovations International on 10 of the 12 factors compared between the two stocks.
About SS Innovations International
AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
